Antibody-mediated targeting of MARCO on TAMs was shown to repolarize macrophages; reduce tumor growth and metastasis; and enhance the effect of CTLA-4 ICB in murine models of mammary cancer, melanoma, and colon carcinoma [219]. This evidence concerns the gene MARCO and neoplasm.